In early September, a federal jury ruled that Reynolds Vapor Co.'s Vuse Alto product had infringed on three Altria patents. As a result, a district court ordered Reynolds to pay $95.23 million to Altria. Reynolds has appealed for a retrial in that court.
Renault Atomizers stated in their request for a retrial that "Altria improperly injected incendiary evidence regarding patent infringement allegations against Renault in other cases, depriving Renault of a fair trial. The erroneous ruling also damaged Renault's ability to defend itself. Under the cumulative error theory, these errors independently impacted the judgment and thus require a complete new trial.
Tobacco company Altria stated that they consider the court ruling to be fair and that they are glad the jury correctly recognized that R.J. Reynolds had infringed on some of their patents. They also stated that there is no need for another trial.
The complaint involves three patents granted by the United States to Altria's customer service. The patents were based on an application from April 2015, according to the Patent and Trademark Office.
Altria claimed that Reynolds' vaporizer infringed on Altria's patent for the pod component used in Vuse Alto.
Renault believes that Altria's lawsuit is in retaliation for Renault's patent infringement complaint filed in April 2020, which involved six Reynolds patents and alleged that Philip Morris International's IQOS tobacco heating device infringed on them. Altria was the exclusive distributor of IQOS in the United States until recently.
On September 29, 2021, the United States International Trade Commission upheld a preliminary decision made in May 2021, ruling that the IQOS device produced by Philip Morris International infringes on two patents owned by rival company Renault. As a result of this decision, the Altria Group is prohibited from importing IQOS products into the United States.
Statement:
This article is compiled from third-party information and is intended for industry sharing and learning purposes only.
This article does not represent the viewpoint of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.
Due to limitations in the level of translation, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.
2FIRSTS fully aligns with the Chinese government on any domestic, Hong Kong, Macau, Taiwan and foreign related statements and positions.
The compilation of information is the property of the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
